| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J F Quist, C L Barr, R Schachar, W Roberts, M Malone, R Tannock, V S Basile, J Beitchman, J L Kenned. Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Molecular psychiatry. vol 5. issue 5. 2001-02-01. PMID:11032388. |
the complex interaction between the serotonergic and dopaminergic neurotransmitter systems suggests that a balance between the two systems may be necessary for mediating hyperactive behaviour. |
2001-02-01 |
2023-08-12 |
mouse |
| M Kapsimali, H Dumond, S Le Crom, S Coudouel, J D Vincent, P Vernie. [Evolution and development of dopaminergic neurotransmitter systems in vertebrates]. Journal de la Societe de biologie. vol 194. issue 2. 2001-01-18. PMID:11098433. |
[evolution and development of dopaminergic neurotransmitter systems in vertebrates]. |
2001-01-18 |
2023-08-12 |
Not clear |
| S L Minger, M M Esiri, B McDonald, J Keene, J Carter, T Hope, P T Franci. Cholinergic deficits contribute to behavioral disturbance in patients with dementia. Neurology. vol 55. issue 10. 2001-01-04. PMID:11094098. |
this study investigated the relationship between markers of the cholinergic and dopaminergic neurotransmitter systems and noncognitive behavioral symptoms assessed during the course of dementing illness. |
2001-01-04 |
2023-08-12 |
Not clear |
| J Kulisevsk. Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs & aging. vol 16. issue 5. 2000-11-13. PMID:10917074. |
enhancement and impairment of cognitive function with dopaminergic treatment is incomplete and task-specific, suggesting the need to integrate the above dopamine facts with other neurotransmitter systems findings in pd. |
2000-11-13 |
2023-08-12 |
human |
| N S Lamango, C G Charlto. Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats. Pharmacology, biochemistry, and behavior. vol 66. issue 4. 2000-11-07. PMID:10973524. |
these data indicate that intracerebroventricular injection of sam may induce pd symptoms by interfering with the methylation/demethylation homeostasis of prenylated proteins that function in the dopaminergic and other signaling pathways, and that the fc analogs may counteract the sam effects by acting synergistically on events subsequent to neurotransmitter release. |
2000-11-07 |
2023-08-12 |
rat |
| M Martin-Negrier, G Charron, B Bloc. Agonist stimulation provokes dendritic and axonal dopamine D(1) receptor redistribution in primary cultures of striatal neurons. Neuroscience. vol 99. issue 2. 2000-10-19. PMID:10938431. |
to investigate the influence of neurotransmitter on g-protein-coupled receptor trafficking and compartimentalization in neurons, we have developed a model of primary neuronal cultures from fetal rat striatum on which we have studied the cellular and subcellular distribution and trafficking of the d(1) dopaminergic receptor. |
2000-10-19 |
2023-08-12 |
rat |
| M Hansenn. [The p300 cognitive event-related potential. I. Theoretical and psychobiologic perspectives]. Neurophysiologie clinique = Clinical neurophysiology. vol 30. issue 4. 2000-10-19. PMID:11013894. |
psychopharmacological studies have shown that different neurotransmitter systems are involved in the generation and modulation of p300, namely the cholinergic, noradrenergic, dopaminergic, serotoninergic and gabaergic systems. |
2000-10-19 |
2023-08-12 |
human |
| J M Rumsey, M Erns. Functional neuroimaging of autistic disorders. Mental retardation and developmental disabilities research reviews. vol 6. issue 3. 2000-10-16. PMID:10982494. |
neurotransmitter studies using positron emission tomography (pet) suggest abnormalities of serotonergic and dopaminergic function. |
2000-10-16 |
2023-08-12 |
human |
| G P Galloway, S L Frederick-Osborne, R Seymour, S E Contini, D E Smit. Abuse and therapeutic potential of gamma-hydroxybutyric acid. Alcohol (Fayetteville, N.Y.). vol 20. issue 3. 2000-08-11. PMID:10869868. |
gamma-hydroxybutyric acid effects dopaminergic systems in the brain and may be a neurotransmitter. |
2000-08-11 |
2023-08-12 |
human |
| A G Sanz, A Badia, M V Clo. Role of calcium on the modulation of spontaneous acetylcholine efflux by the D2 dopamine receptor subtype in rat striatal synaptosomes. Brain research. vol 854. issue 1-2. 2000-07-27. PMID:10784105. |
although 1 microm of 7-hydroxy-n,n-di-n-propyl-2-aminotetraline (7-oh-dpat) inhibited spontaneous [3h]ach efflux in the presence of calcium, this dopaminergic agonist did not modify the neurotransmitter release in either the low-ca2+ medium or in the presence of vesamicol. |
2000-07-27 |
2023-08-12 |
rat |
| P Teismann, B Ferge. Comparison of the novel drug Ensaculin with MK-801 on the reduction of hydroxyl radical production in rat striatum after local application of glutamate. Brain research. vol 857. issue 1-2. 2000-05-04. PMID:10700564. |
ensaculin interacts with various neurotransmitter systems (e.g., dopaminergic, serotoninergic, glutamatergic) and was originally designed for the treatment of dementia. |
2000-05-04 |
2023-08-12 |
rat |
| T H Rammsayer, S Rodewald, D Gro. Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions. Brain research. Cognitive brain research. vol 9. issue 1. 2000-04-11. PMID:10666558. |
the overall pattern of results revealed that memory processes are much more susceptible to changes in gabaergic than in dopaminergic or cholinergic neurotransmitter activity. |
2000-04-11 |
2023-08-12 |
human |
| T H Rammsayer, S Rodewald, D Gro. Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions. Brain research. Cognitive brain research. vol 9. issue 1. 2000-04-11. PMID:10666558. |
furthermore, the present findings point to the conclusion that the modulating effects of dopaminergic, gabaergic, and cholinergic neurotransmitter systems on declarative and procedural memory functions are less specific than suggested by neuropsychological studies in patients. |
2000-04-11 |
2023-08-12 |
human |
| J Hennig, C Toll, P Schonlau, S Rohrmann, P Nette. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality. Neuropsychobiology. vol 41. issue 1. 2000-03-21. PMID:10629434. |
the tridemensional model of personality introduced by cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (ha) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. |
2000-03-21 |
2023-08-12 |
human |
| R Schlösse. [Detection of neurotransmitter interactions with PET and SPECT by pharmacological challenge paradigms]. Der Nervenarzt. vol 71. issue 1. 2000-03-21. PMID:10695027. |
especially, interactions of different neurotransmitter systems with the dopaminergic and the cholinergic system will be discussed. |
2000-03-21 |
2023-08-12 |
human |
| A Serretti, F Benedetti, C Colombo, R Lilli, C Lorenzi, E Smerald. Dopamine receptor D4 is not associated with antidepressant activity of sleep deprivation. Psychiatry research. vol 89. issue 2. 2000-02-08. PMID:10646829. |
total sleep deprivation (tsd) is an effective treatment for mood disorders which is thought to act through an enhancement in several neurotransmitter pathways including dopaminergic transmission. |
2000-02-08 |
2023-08-12 |
Not clear |
| R Lints, S W Emmon. Patterning of dopaminergic neurotransmitter identity among Caenorhabditis elegans ray sensory neurons by a TGFbeta family signaling pathway and a Hox gene. Development (Cambridge, England). vol 126. issue 24. 2000-01-21. PMID:10572056. |
patterning of dopaminergic neurotransmitter identity among caenorhabditis elegans ray sensory neurons by a tgfbeta family signaling pathway and a hox gene. |
2000-01-21 |
2023-08-12 |
caenorhabditis_elegans |
| P T Trzepac. Update on the neuropathogenesis of delirium. Dementia and geriatric cognitive disorders. vol 10. issue 5. 1999-11-18. PMID:10473933. |
an imbalance in the cholinergic and dopaminergic neurotransmitter systems is most commonly implicated in causing delirium, and could both account for delirium symptoms and be consistent with the neuroanatomical pathways being implicated. |
1999-11-18 |
2023-08-12 |
Not clear |
| J S Baffi, M Palkovits, S O Castillo, E Mezey, V M Nikode. Differential expression of tyrosine hydroxylase in catecholaminergic neurons of neonatal wild-type and Nurr1-deficient mice. Neuroscience. vol 93. issue 2. 1999-10-07. PMID:10465447. |
subsequent analysis revealed the absence of neurotransmitter dopamine and tyrosine hydroxylase immunoreactivity in the central dopaminergic area of newborn pups. |
1999-10-07 |
2023-08-12 |
mouse |
| S Rahman, T W Robbins, B J Sahakia. Comparative cognitive neuropsychological studies of frontal lobe function: implications for therapeutic strategies in frontal variant frontotemporal dementia. Dementia and geriatric cognitive disorders. vol 10 Suppl 1. 1999-10-01. PMID:10436335. |
finally, we evaluate critically the rationales for therapeutic modulation of noradrenergic, serotonergic and dopaminergic neurotransmitter systems at various stages of disease. |
1999-10-01 |
2023-08-12 |
Not clear |